NYSE · AXR

AMREP Corporation

$23.09 -$2.32 (-9.13%) 1D Market open
Session Pulse After hours 2 mentions on Fri · 0 bullish / 1 bearish tags No new SEC filings since Tue close its sector ranked 8/11 this week Full pulse →

Key Metrics

$134.81M
Market cap
10.42×
P/E · TTM
$53.00M
Revenue · TTM
$12.93M
Net income
EPS · TTM $2.40
Dividend yield
Free cash flow $13.11M
Beta · 1Y 1.03
EBITDA · TTM $15.77M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    The stock moved -9.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 27
  • Jul 24
    A material event was filed (Form 8-K).

    8-K - AMREP CORP. (0000006207) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 16
    The stock moved +15.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 16

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$134.81M
Enterprise value$84.83M
Shares outstanding5.3M
52-wk range$17.61 – $29.01
Avg volume · 20D13.0K
Net cash $49.98M
Book value / share$25.89
IndustryLand Subdividers & Developers (No Cemeteries)
ExchangeNYSE
About AMREP Corporation
IPO dateJun 1, 1972
Employees49

Amrep Corp through its subsidiaries is engaged in the Real estate business.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E10.42
P/S2.54
P/FCF10.28
EV/EBITDA5.38
EV/Sales1.60
Graham №$37.40

Profitability

Gross
Operating 29.2%
Net 24.4%
FCF 24.7%
ROE / ROIC 10.0% · 14.5%

Financial Health

Current ratio
Quick ratio
Debt / equity0.00
Debt / EBITDA 0.00Low leverage
Net cash $49.98M
Working capital

Cash Flow · TTM

Operating CF $13.65M
Capex −$536.00K
Free cash flow $13.11M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

19.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$37.40 vs $23.09
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-01-31 · computed by TickerWolf from SEC filings